In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Phil Greenfield

Set Alert for Articles By Phil Greenfield

Latest From Phil Greenfield

ResMed Jumps On Board As Nyxoah Raises €25m For Neurostim Apnea Device

The proceeds from the investment will enable Nyxoah to prepare for the IDE pivotal trial of the Genio system in the US, and accelerate market access and commercialization activities in Europe, Australia and New Zealand.

Financing Clinical Trials

Editor's Note: Tell Us Your Views In Our Customer Survey

We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you would like to see in the format of the content or the method in which you receive and access Medtech Insight, or if you love it how it is, now is the time to have your voice heard.

Knees Boost Zimmer Biomet; Turnaround Continues, But FDA Woes Linger

Zimmer Biomet reported Q4 results that reflected solid progress in the company’s turnaround efforts, with knees leading the charge. But the company is making slower-than-expected progress resolving FDA warning letter issues and faces a new bribery lawsuit in Mexico.

Companies Commercial

Import Tax Waivers As China Battles Virus

Items subject to the exemption include diagnostic testing agents, sanitization supplies and protective gear. The tax waiver also applies to donated supplies to contain the 2019-nCoV outbreak, and related imported goods ordered by health authorities.

China Infectious Diseases

Diagnostics Sector On High Alert As Wuhan Coronavirus Spreads

The latest figures from China's National Health Commission show infections of the new Wuhan coronavirus are continuing to pile up, spreading to more cities in the country and abroad as travel for the Lunar New Year festival goes into high gear. Meanwhile, diagnostics companies are rushing to have test kits ready.

China In Vitro Diagnostics

Google/DeepMind Tech Could ‘Transform Double-Reading In Mammography’

An algorithm has been shown to be as effective as radiologists in spotting breast cancer from mammograms, backing previous predictions that machine learning will find increasing use as a "second reader" in screening programs.

Artificial Intelligence Medical Device
See All
UsernamePublicRestriction

Register